These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 458172)

  • 41. [Exposure to diethylstilbestrol during intrauterine life. Signs that should suggest this. Therapeutic implications].
    Belaïsch J
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(5):481-8. PubMed ID: 6655208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reproductive performance among DES exposed daughters compared with that of their mothers.
    Kirkhope TG
    Ohio State Med J; 1983 Nov; 79(11):867-9. PubMed ID: 6646562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy.
    Herbst AL
    J Toxicol Environ Health Suppl; 1976; 1():13-20. PubMed ID: 994230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In utero diethylstilbestrol exposure: structural and epithelial abnormalities.
    Noller KL
    Cervix Low Female Genital Tract; 1983; 1(2):75-82. PubMed ID: 12266371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women.
    DeMars LR; Van Le L; Huang I; Fowler WC
    Gynecol Oncol; 1995 Sep; 58(3):389-92. PubMed ID: 7672708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities.
    Gill WB; Schumacher GF; Bibbo M; Straus FH; Schoenberg HW
    J Urol; 1979 Jul; 122(1):36-9. PubMed ID: 37351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiological studies of the effects of diethylstilboestrol.
    Vessey MP
    IARC Sci Publ; 1989; (96):335-48. PubMed ID: 2680951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of breast cancer in patients prenatally exposed to diethylstilbestrol: are we prepared?
    Mano MS; Kerr J; Kennedy J
    Breast; 2005 Oct; 14(5):408-10. PubMed ID: 16216745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prenatal diethylstilbestrol exposure and breast cancer].
    Frigo S; Malina C; Mathelin C
    Gynecol Obstet Fertil; 2012 Dec; 40(12):784-6. PubMed ID: 23102737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy.
    Titus-Ernstoff L; Hatch EE; Hoover RN; Palmer J; Greenberg ER; Ricker W; Kaufman R; Noller K; Herbst AL; Colton T; Hartge P
    Br J Cancer; 2001 Jan; 84(1):126-33. PubMed ID: 11139327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preeclampsia risk in women exposed in utero to diethylstilbestrol.
    Troisi R; Titus-Ernstoff L; Hyer M; Hatch EE; Robboy SJ; Strohsnitter W; Palmer JR; Øglaend B; Adam E; Kaufman R; Herbst AL; Hoover RN
    Obstet Gynecol; 2007 Jul; 110(1):113-20. PubMed ID: 17601905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maternal stilbestrol--genital adenocarcinoma--and follow-up of exposed young women.
    J Miss State Med Assoc; 1973 Jul; 14(7):301-3. PubMed ID: 4732650
    [No Abstract]   [Full Text] [Related]  

  • 53. Recommendations of DES Task Force.
    NAACOG Newsl; 1986 Aug; 13(8):9-10. PubMed ID: 3092043
    [No Abstract]   [Full Text] [Related]  

  • 54. By the way, doctor. My mother took DES when she was pregnant with me. I'm now 69, my daughter is 41, and we've both had gynecological problems. What particular risks do we have because of our DES exposure, and what can we do about them?
    Richardson MK
    Harv Womens Health Watch; 2010 May; 17(9):7. PubMed ID: 20593559
    [No Abstract]   [Full Text] [Related]  

  • 55. Induction of urogenital neoplasia and abnormalities from prenatal exposure to diethylstilbestrol.
    Netzloff ML
    Ann Clin Lab Sci; 1979; 9(4):263-7. PubMed ID: 485089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DES-related clear cell adenocarcinoma of the vagina in pregnancy.
    Jones WB; Woodruff JM; Erlandson RA; Lewis JL
    Obstet Gynecol; 1981 Jun; 57(6 Suppl):76S-80S. PubMed ID: 7243130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary tract evaluation of diethylstilbestrol-exposed female progeny followed in a colposcopy clinic.
    Gallup DG; Altaffer LF; Castle CA
    J Reprod Med; 1984 Oct; 29(10):717-21. PubMed ID: 6512780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultrasound detection of uterine abnormalities after diethylstilbestrol (DES) exposure.
    Viscomi GN; Gonzalez R; Taylor KJ
    Radiology; 1980 Sep; 136(3):733-5. PubMed ID: 7403556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vulnerability to stress among women with in utero diethylstilbestrol (DES) exposed daughters.
    Gutterman EM; Ehrhardt AA; Markowitz JS; Link BG
    J Human Stress; 1985; 11(3):103-10. PubMed ID: 3855173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genital clear cell adenocarcinoma.
    Johnston GA; Jones HA
    Int Surg; 1983; 68(3):257-61. PubMed ID: 6662641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.